null
ChEBI ID: 39307
| Member | Definition | Role |
|---|---|---|
| cenicriviroc | A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH). | cenicriviroc |
| metazocine | metazocine | |
| pentazocine | Talwin | |
| pentazocine | pentazocine |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1,468 (68.25) | 18.7374 |
| 1990's | 315 (14.64) | 18.2507 |
| 2000's | 161 (7.48) | 29.6817 |
| 2010's | 158 (7.35) | 24.3611 |
| 2020's | 49 (2.28) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 365 (15.66%) | 5.53% |
| Reviews | 84 (3.60%) | 6.00% |
| Case Studies | 170 (7.29%) | 4.05% |
| Observational | 1 (0.04%) | 0.25% |
| Other | 1,711 (73.40%) | 84.16% |